As per MRFR analysis, the US Upper GI Series Market Size was estimated at 548.1 (USD Million) in 2023. The US Upper GI Series Market Industry is expected to grow from 570(USD Million) in 2024 to 1,050 (USD Million) by 2035. The US Upper GI Series Market CAGR (growth rate) is expected to be around 5.711% during the forecast period (2025 - 2035).
The US Upper GI Series Market has been experiencing several important trends recently. There has been a notable increase in the adoption of advanced imaging technologies, which has improved the accuracy and efficiency of upper gastrointestinal examinations. The rising prevalence of gastrointestinal disorders, driven by lifestyle factors and dietary changes in the US population, has also led to a heightened demand for diagnostic procedures like the Upper GI series.
Healthcare providers are now more frequently using these series to diagnose conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers. A key market driver is the growing emphasis on preventive healthcare, with a focus on early detection and treatment of gastrointestinal issues. As awareness about the importance of gastrointestinal health increases among the US population, more individuals are seeking medical advice and diagnostic services, contributing to a rise in upper GI series procedures.
Additionally, technological advancements and the integration of artificial intelligence in imaging systems are opening new opportunities to enhance diagnostic capabilities and improve patient outcomes. Recent trends also indicate a shift toward outpatient services, driven by the need for cost-effective healthcare solutions and patient convenience. This transition is further supported by government initiatives aimed at improving access to care and ensuring more efficient healthcare delivery systems.
Moreover, as telemedicine continues to grow, there are potential opportunities for virtual consultations leading up to diagnostic procedures like the Upper GI series. The convergence of these trends presents a fertile landscape for growth in the US Upper GI Series Market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Upper GI Series Market Industry is experiencing significant growth due to the rising incidence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD) and peptic ulcers. According to the American Gastroenterological Association, gastritis and GERD affect approximately 20% of the adult population in the United States. This increasing prevalence drives the demand for diagnostic procedures like upper gastrointestinal series, as healthcare providers aim to diagnose and manage these conditions effectively.
Major healthcare institutions such as the Mayo Clinic are emphasizing the need for improved diagnostic tools, which directly impacts the growth of the upper GI series market. Furthermore, the Centers for Disease Control and Prevention (CDC) noted that lower gastrointestinal diseases are contributing to healthcare burdens, creating a ripple effect that increases the need for upper GI diagnostics. Such statistics underline the imperative nature of upper GI diagnostics within the healthcare landscape, promoting market growth.
Technological advancements in imaging techniques significantly drive the US Upper GI Series Market Industry. The introduction of high-definition imaging and digital fluoroscopy allows for enhanced visualization and diagnostic accuracy, leading to increased adoption by medical practitioners. According to the Radiological Society of North America, innovations in imaging technologies are improving the detection rates of gastrointestinal conditions, which is essential for timely treatments.
Organizations like Siemens Healthineers are at the forefront of developing state-of-the-art imaging systems that streamline the workflow in radiology departments. Such advancements not only enhance patient outcomes but also encourage healthcare facilities to invest in modern upper GI series technologies, thus propelling market growth in the United States.
The growing awareness of gastrointestinal health and emphasis on preventive healthcare measures are contributing to the expansion of the US Upper GI Series Market Industry. With campaigns from organizations like the American Cancer Society focusing on promoting digestive health, the public is now more informed about the potential risks associated with gastrointestinal diseases. This heightened awareness encourages individuals to seek diagnostic tests such as upper gastrointestinal series, even in asymptomatic stages.
Additionally, government health initiatives aimed at early detection and prevention of diseases are catalyzing the demand for diagnostic imaging. The United States Prevention Services Task Force is advocating for more rigorous screening protocols that include upper GI evaluations, thereby enhancing the overall growth prospects of the market.
The US Upper GI Series Market has been increasingly focusing on various test types, particularly the standard barium upper GI series and the double-contrast upper GI series, each serving distinct diagnostic purposes. The standard barium upper GI series is a widely utilized imaging technique that helps in detecting abnormalities in the esophagus, stomach, and the initial part of the small intestine. This method usually employs a barium sulfate contrast agent which provides clear visuals for issues such as tumors, ulcers, or strictures, thereby making it significant for practitioners and patients alike.
Meanwhile, the double-contrast upper GI series enhances imaging quality by using both a barium solution and air, allowing for a more detailed view of the gastrointestinal tract. This technique is particularly effective in the identification of subtle lesions, making it valuable in early cancer detection and assessment of disease severity. The focus on these test types in the US is reinforced by the growing awareness and advancements in medical imaging technology, which have enabled more accurate diagnoses and treatment planning.
As healthcare systems continue to shift towards preventive care, these test types are becoming increasingly crucial, especially in populations at high risk for gastrointestinal disorders. Furthermore, as the US demographic trends point towards an aging population, the demand for reliable imaging techniques to monitor gastrointestinal health is expected to increase. In addition, ongoing developments in contrast materials and imaging equipment are anticipated to refine the efficacy of these tests, further solidifying their importance in clinical settings.
Collectively, the emphasis on standard barium upper GI series and double-contrast upper GI series in the US market underscores a commitment to improving diagnostic capabilities in gastrointestinal health. By addressing common gastrointestinal diseases and aiding in the early detection of potential ailments, these test types hold a significant position in the overall framework of the US Upper GI Series Market, ensuring that healthcare providers can meet the growing diagnostic needs of their patients. The evolving landscape of this market suggests promising opportunities for enhancing patient outcomes and advancing medical technologies in the field of upper gastrointestinal diagnostics.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Type of Imaging Material segment within the US Upper GI Series Market plays a crucial role in diagnostic imaging, primarily utilized for assessments of the esophagus, stomach, and the upper part of the small intestine. The predominant materials in this segment include barium swallow, barium meal, and barium follow-through, each serving specific diagnostic purposes. Barium swallow is essential for detecting abnormalities in swallowing and esophageal function, allowing healthcare professionals to identify conditions like strictures or tumors.
Barium meal provides a comprehensive view of the stomach lining and any potential lesions, while barium follow-through aids in examining the small intestine for obstructions or inflammatory conditions. The increasing prevalence of gastrointestinal disorders in the US is driving demand in this segment, with substantial investment in imaging technology further enhancing the effectiveness and efficiency of these procedures. Overall, advancements in radiology techniques are expected to increase the adoption of these imaging materials, providing significant opportunities for growth in the US Upper GI Series Market. The market continues to evolve as healthcare providers seek to improve diagnostic capabilities and patient outcomes, highlighting the importance of this segment in gastrointestinal diagnostics.
The Application segment of the US Upper GI Series Market encompasses various critical conditions that require precise diagnostic imaging. This segment includes significant health issues such as esophageal reflux, which affects a large population due to lifestyle factors and diet, leading to increased demand for accurate assessments. Esophageal varices, often associated with liver disease, require careful monitoring and interventions that enhance their importance in clinical practice.
Ulcers and hiatal hernias represent prevalent concerns, as they pose risks for gastrointestinal complications. The majority of the market's focus is on these conditions, driven by rising awareness and healthcare initiatives promoting early detection. The emphasis on preventive healthcare is expected to further bolster the utilization of upper GI series examinations across the US. Additionally, advancements in imaging technologies offer new opportunities for improved diagnosis and treatment plans, catering to the significant patient population experiencing these gastrointestinal disorders. The Application segment is crucial, playing a key role in enhancing diagnostic accuracy and patient outcomes, thus contributing to the overall growth of the US Upper GI Series Market industry.
The US Upper GI Series Market showcases a diverse range of end users, which primarily include hospitals, clinics, laboratories, and other healthcare facilities. Hospitals represent a significant portion of this market as they are equipped with advanced imaging technologies and offer comprehensive diagnostic services, thus driving demand for upper gastrointestinal procedures. Clinics also play an essential role by providing outpatient services and facilitating quick diagnostics, contributing to the overall efficiency in the healthcare system.
Laboratories, while more specialized, are crucial for processing and interpreting the imaging results, ensuring accurate diagnoses are made in a timely manner. In addition to these, other healthcare settings such as educational institutions and research facilities also leverage upper GI series for various medical and research purposes. The growth in this market is propelled by increasing incidences of gastrointestinal disorders, advancements in imaging technologies, and a rising emphasis on preventive healthcare measures. Furthermore, the ongoing enhancements in healthcare infrastructure in the US support increased accessibility to these diagnostic services. Overall, the end users in the US Upper GI Series Market cater to a wide range of patient needs, significantly impacting the overall diagnostics and treatment landscape in the country.
The US Upper GI Series Market is characterized by a dynamic competitive landscape where various players strive to establish their foothold through innovation and advancements in imaging technologies. This market focuses on diagnostic imaging procedures that examine the upper gastrointestinal tract, facilitating the identification of numerous gastrointestinal conditions. The competition ranges from established medical device manufacturers to specialized healthcare technology firms, each aiming to leverage their technological strengths, improve patient outcomes, and enhance diagnostic efficiency.
The entry of novel technologies, such as artificial intelligence and cloud-based imaging solutions, has further intensified competition, compelling companies to prioritize R&D and tailored customer service to maintain their market positions. With the growing prevalence of gastrointestinal diseases in the US, the market continues to attract significant investments, aiming to address the increasing demand for non-invasive diagnostics in clinical settings.
Siemens Healthineers has made a significant impact in the US Upper GI Series Market by offering advanced imaging solutions characterized by high-quality imaging and efficiency. The company is recognized for its commitment to innovation, providing a range of diagnostic imaging equipment that includes cutting-edge fluoroscopy and digital radiography systems. Siemens Healthineers has increasingly focused on developing technologies that integrate artificial intelligence, enhancing diagnostic accuracy and providing added value to healthcare providers.
Their robust portfolio enables them to address the varying needs of the US market, ensuring that they remain competitive. The company's strong presence in the healthcare sector is underscored by their extensive partnerships and collaborations with hospitals and imaging centers across the country, solidifying their reputation as a trusted partner in gastrointestinal diagnostics.
AgfaGevaert has established itself as a key player in the US Upper GI Series Market through its comprehensive offerings in imaging solutions, including its advanced digital radiography equipment and imaging software. The company's strength lies in its innovative approach to enhancing workflow efficiency and diagnostic accuracy, with products designed specifically for various medical imaging applications, including the gastrointestinal segment. AgfaGevaert has been active in forging strategic partnerships and collaborations that bolster its market presence, allowing the company to streamline its services and expand its reach within the US healthcare system.
Their emphasis on continuous improvement and adaptation to market needs reflects their commitment to delivering high-quality solutions. Notably, AgfaGevaert has pursued various mergers and acquisitions to consolidate its market position and expand its technological capabilities, further reinforcing its commitment to providing superior imaging solutions tailored to the demands of the US Upper GI Series Market.
The US Upper GI Series Market has experienced several noteworthy developments recently. Siemens Healthineers launched a new digital imaging suite which enhances the diagnostic capability for gastrointestinal disorders, demonstrating a commitment to innovation. AgfaGevaert reported an increase in demand due to advancements in imaging technologies, allowing for better patient outcomes. Furthermore, GE Healthcare has released new imaging software that optimizes Upper GI procedures, reflecting their focus on enhancing efficiency.
Notably, in July 2023, Bracco Imaging announced its acquisition of a competitor in the imaging sector, strengthening its position in the market. In the same vein, in September 2023, Hitachi Medical Corporation emphasized its growth strategy through the development of advanced imaging systems tailored for gastrointestinal diagnostics. The market has seen a valuation growth, notably due to increased investments in Research and Development by Canon Medical Systems and Fujifilm Holdings. Moreover, the ongoing integration of Artificial Intelligence in imaging processes is reshaping operational workflows and accuracy in diagnostics. Overall, these advancements and collaborations are driving significant improvements in the US Upper GI Series Market, enhancing clinical performances and meeting the evolving needs of healthcare providers.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 548.1(USD Million) |
| MARKET SIZE 2024 | 570.0(USD Million) |
| MARKET SIZE 2035 | 1050.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.711% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Siemens Healthineers, AgfaGevaert, GE Healthcare, Varian Medical Systems, Bracco Imaging, Hitachi Medical Corporation, Medtronic, Variable Mobile Imaging, Elekta, Canon Medical Systems, Fujifilm Holdings, Hologic, Carestream Health, Boston Scientific, Philips Healthcare |
| SEGMENTS COVERED | Test Types, Type of Imaging Material, Application, End Users |
| KEY MARKET OPPORTUNITIES | Growing prevalence of gastrointestinal disorders, Advancements in imaging technology, Increasing demand for non-invasive diagnostics, Rising elderly population needing screenings, Expansion of outpatient diagnostic services |
| KEY MARKET DYNAMICS | rising GERD prevalence, technological advancements, increasing aging population, growing awareness, regulatory changes |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Upper GI Series Market is expected to be valued at 570.0 million USD in 2024.
By 2035, the overall market is projected to grow to 1050.0 million USD.
The expected CAGR for the US Upper GI Series Market during this period is 5.711 percent.
The standard barium upper GI series is anticipated to dominate the market with a valuation of 300.0 million USD in 2024.
The double-contrast upper GI series is expected to reach a market size of 500.0 million USD by 2035.
Major players include Siemens Healthineers, GE Healthcare, and Phillips Healthcare among others.
Advancements in imaging technologies are considered a significant driver for market growth.
Regulatory hurdles and market competition are potential challenges hindering market growth.
The competitive landscape is evolving with new entrants and innovations from established players.
Emerging trends include the increase in minimally invasive procedures and the integration of AI in imaging.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
